Document:

ASSET
PURCHASE AGREEMENT

 

This
Asset Purchase Agreement (this “Agreement”), dated as of April 4, 2016 is entered into between Turnaround Strategies,
Inc., a Florida corporation as assignee (“Assignee”) for the assets of WeedHire International, Inc., a Delaware
corporation, and AnythingIT, LLC, a Delaware limited liability company (“Buyer”).

 

RECITALS

 

WHEREAS,
WeedHire International, Inc. filed an Assignment for the Benefit of Creditors proceeding in Delaware Court of Chancery (“Court”)
pursuant to Title 10 Section 73, §7381-87 Delaware Code (“ABC Statute”) and assigned its assets to Assignee,
which is the Seller under this Agreement (“Seller”).

 

WHEREAS,
Seller wishes to sell and assign to Buyer, and Buyer wishes to purchase and assume from Seller, the rights and obligations of
Seller to the Purchased Assets and the Assumed Liabilities (as defined herein), subject to the terms and conditions set forth
herein;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

Article
I

Purchase
and Sale

 

Section
1.01Purchase and Sale of Assets. Subject to the terms and conditions set forth herein, Seller shall sell, assign, transfer,
convey and deliver to Buyer, and Buyer shall purchase from Seller, all of Seller’s right, title and interest in the assets
set forth on Section 1.01 of the disclosure schedules (“Disclosure Schedules”)
attached hereto (the “Purchased Assets”), except for the representations
set forth below, the Purchased Assets are sold “AS-IS” without any warranties, express or implied as to the condition
of the Purchased Assets.

 

Section
1.02Assumption of Liabilities. Subject to the terms and conditions set forth herein, Buyer shall assume and agree to pay,
perform and discharge the liabilities and obligations set forth on Section 1.02 of the Disclosure Schedules under the Purchased
Assets, but only to the extent of the amounts set forth in Section 1.02 of the Disclosure Schedules (collectively, the
“Assumed Liabilities”). Other than the Assumed Liabilities, Buyer shall not
assume any liabilities or obligations of Seller of any kind, whether known or unknown, contingent, matured or otherwise, whether
currently existing or hereinafter created.

 

Section
1.03Purchase Price. The aggregate purchase price for the Purchased Assets shall be $35,000 in cash (the “Purchase
Price”) plus the assumption of the Assumed Liabilities. The Buyer shall pay the Purchase Price to Seller at the
Closing (as defined herein) in cash, by wire transfer of immediately available funds in accordance with the wire transfer instructions
set forth in Section 1.03 of the Disclosure Schedules.

 

    	 	 	 

    	 

    

 

Article
II

Closing

 

Section
2.01Closing. The closing of the transactions contemplated by this Agreement (the “Closing”)
shall take place as soon as practicable (the “Closing Date”) at the offices
of Rice Pugatch Robinson Storfer & Cohen, PLLC, 101 NE Third Avenue, Suite 1800, Fort Lauderdale, Florida 33301. The consummation
of the transactions contemplated by this Agreement shall be deemed to occur at 12:01 a.m. on the Closing Date.

 

Section
2.02Closing Deliverables

 

(a)At
the Closing, Seller shall deliver to Buyer the following:

 

(i)a
bill of sale in form and substance satisfactory to Buyer (the “Bill of Sale”) and duly executed by Seller,
transferring the Purchased Assets to Buyer;

 

(ii)an
assignment and assumption agreement in form and substance satisfactory to Buyer (the “Assignment and Assumption Agreement”)
and duly executed by Seller, effecting the assignment to and assumption by Buyer of the Purchased Assets and the Assumed Liabilities;

 

(iii)an
Assignment and Assumption of Lease in form and substance satisfactory to Buyer (the “Assignment and Assumption of Lease”)
and duly executed by Seller and the landlord;

 

(iv)such
other customary instruments of transfer, assumption, filings or documents, in form and substance reasonably satisfactory to Buyer,
as may be required to give effect to this Agreement.

 

(b)At
the Closing, Buyer shall deliver to Seller the following:

 

(i)the
Purchase Price;

 

(ii)the
Assignment and Assumption Agreement duly executed by Buyer;

 

(iii)the
Assignment and Assumption of Lease duly executed by Buyer; and

 

Section
2.03Closing Conditions Buyer shall not be required to consummate the Closing and may terminate this Agreement if any of
the following occur:

 

(a)Any
Assumed Liability is in excess of the amount listed on Schedule 1.03;

 

(b)There
is a material adverse change in Seller’s business or the assets between the date of this Agreement and the Closing Date.

 

(c)The
Seller has filed a petition in bankruptcy under any provisions of federal or state bankruptcy Law or consent to the filing of
any bankruptcy petition against it under any similar law.

 

(d)An
action, suit, investigation or proceeding shall have been instituted or threatened by any third party, governmental or regulatory
agency to restrain, prohibit or otherwise challenge the legality or validity of the transactions contemplated by this Agreement.

 

    	 	2	 

    	 

    

 

Article
III

Representations
and warranties of seller

 

To
the best of the Seller’s knowledge and belief, Seller represents and warrants to Buyer that the statements contained in
this Article III are true and correct as of the date hereof. For purposes of this Article III, “Seller’s
knowledge,” “knowledge of Seller” and any similar phrases shall mean the actual or constructive knowledge of
any director or officer of Seller, after due inquiry.

 

Section
3.01Authority of Seller; Enforceability. Seller has full corporate power and authority to enter into this Agreement and
the documents to be delivered hereunder, to carry out its obligations hereunder and to consummate the transactions contemplated
hereby. The execution, delivery and performance by Seller of this Agreement and the documents to be delivered hereunder and the
consummation of the transactions contemplated hereby have been duly authorized by all requisite corporate action on the part of
Seller. This Agreement and the documents to be delivered hereunder have been duly executed and delivered by Seller, and (assuming
due authorization, execution and delivery by Buyer) this Agreement and the documents to be delivered hereunder constitute legal,
valid and binding obligations of Seller, enforceable against Seller in accordance with their respective terms.

 

Section
3.02Consents. Seller has fully complied with all of the requirements of the ABC Statute and no further approvals are required
by the Assignee or the Seller in order to consummate the transactions contemplated by this Agreement. No consent, approval, waiver
or authorization is required to be obtained by Seller from any person or entity (including any governmental authority) in connection
with the execution, delivery and performance by Seller of this Agreement and the consummation of the transactions contemplated
hereby.

 

Section
3.03Title to Purchased Assets. Seller owns and has good title to the Purchased Assets.

 

Section
3.04Legal Proceedings. There is no claim, action, suit, proceeding or governmental investigation (“Action”)
of any nature pending or, to Seller’s knowledge, threatened against or by Seller (a) relating to or affecting the Purchased
Assets or the Assumed Liabilities; or (b) that challenges or seeks to prevent, enjoin or otherwise delay the transactions contemplated
by this Agreement. No event has occurred or circumstances exist that may give rise to, or serve as a basis for, any such Action.

 

Section
3.05As Is. Except for the representations set forth above, the Purchased Assets are sold “AS-IS”
without any warranties, express or implied, as to the condition of the Purchased Assets.

 

    	 	3	 

    	 

    

 

Article
IV

Representations
and warranties of buyer

 

Buyer
represents and warrants to Seller that the statements contained in this Article IV are true and correct as of the date
hereof. For purposes of this Article IV, “Buyer’s knowledge,” “knowledge of Buyer” and any
similar phrases shall mean the actual or constructive knowledge of any director or officer of Buyer, after due inquiry.

 

Section
4.01Organization and Authority of Buyer; Enforceability. Buyer is a corporation duly organized, validly existing and in
good standing under the laws of the state of Delaware. Buyer has full corporate power and authority to enter into this Agreement
and the documents to be delivered hereunder, to carry out its obligations hereunder and to consummate the transactions contemplated
hereby. The execution, delivery and performance by Buyer of this Agreement and the documents to be delivered hereunder and the
consummation of the transactions contemplated hereby have been duly authorized by all requisite corporate action on the part of
Buyer. This Agreement and the documents to be delivered hereunder have been duly executed and delivered by Buyer, and (assuming
due authorization, execution and delivery by Seller) this Agreement and the documents to be delivered hereunder constitute legal,
valid and binding obligations of Buyer enforceable against Buyer in accordance with their respective terms.

 

Section
4.02No Conflicts; Consents. The execution, delivery and performance by Buyer of this Agreement and the documents to be
delivered hereunder, and the consummation of the transactions contemplated hereby, do not and will not: (a) violate or conflict
with the certificate of incorporation, by-laws or other organizational documents of Buyer; or (b) violate or conflict with any
judgment, order, decree, statute, law, ordinance, rule or regulation applicable to Buyer. No consent, approval, waiver or authorization
is required to be obtained by Buyer from any person or entity (including any governmental authority) in connection with the execution,
delivery and performance by Buyer of this Agreement and the consummation of the transactions contemplated hereby.

 

Section
4.03Legal Proceedings. There is no Action of any nature pending or, to Buyer’s knowledge, threatened against or
by Buyer that challenges or seeks to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement. No event
has occurred or circumstances exist that may give rise to, or serve as a basis for, any such Action.

 

Article
V

Covenants

 

Section
5.01Operation in the Ordinary Course. Until the Closing, Seller shall operate the business in the ordinary course.

 

Section
5.02Bulk Sales Laws. The parties hereby waive compliance with the provisions of any bulk sales, bulk transfer or similar
laws of any jurisdiction that may otherwise be applicable with respect to the sale of any or all of the Purchased Assets to Buyer.

 

Section
5.03Transfer Taxes. All transfer, documentary, sales, use, stamp, registration, value added and other such taxes and fees
(including any penalties and interest) incurred in connection with this Agreement and the documents to be delivered hereunder
shall be borne and paid by Buyer when due. Buyer shall, at its own expense, timely file any tax return or other document with
respect to such taxes or fees (and Seller shall cooperate with respect thereto as necessary).

 

    	 	4	 

    	 

    

 

Section
5.04Further Assurances. Following the Closing, each of the parties hereto shall execute and deliver such additional documents,
instruments, conveyances and assurances and take such further actions as may be reasonably required to carry out the provisions
hereof and give effect to the transactions contemplated by this Agreement and the documents to be delivered hereunder.

 

Article
VI

SURVIVAL
OF REPRESENTATIONS AND WARRANTIES

 

Section
6.01Survival. All representations, warranties, covenants and agreements contained herein shall not survive the Closing.

 

Article
VII

Miscellaneous

 

Section
7.01Expenses. All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby
shall be paid by the party incurring such costs and expenses.

 

Section
7.02Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in
writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received
by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or
e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the
next business day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified
or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the
following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section
7.02):

 

	If
    to Seller:	Phil
        Von Kahle

        Michael
        Moecker & Associates, Inc.

        3613
        North 29th Avenue

        Hollywood,
        FL 33020

        Facsimile:
        954-252-2791

        E-mail:
        philv@MOECKER.com

         

	with
    a copy to:	Thomas
        J. Francella, Jr.

        Whiteford
        Taylor & Preston LLC

        Renaissance
        Centre

        405
        N. King Street, Suite 500

        Wilmington,
        DE 19801

        Facsimile:
        302-357-3272

        E-mail:
        tfrancella@wtplaw.com 

 

    	 	5	 

    	 

    

 

	If
    to Buyer:	Anything
        IT, LLC

        17-09
        Zink Place, Unit 1

        Fair
        Lawn, NJ 07410

        Facsimile:201-475-7310

        E-mail:
        daveb@anythingit.com

        Attention:
        David Bernstein

         

	with
    a copy to:	Craig
        A. Pugatch

        Rice
        Pugatch Robinson Storfer & Cohen, PLLC

        101
        NE Third Avenue, Suite 1800

        Fort
        Lauderdale, FL 33301

        Facsimile:
        954-462-4300

        E-mail:
        capugatch@rprslaw.com

 

Section
7.03Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

Section
7.04Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction,
such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or
render unenforceable such term or provision in any other jurisdiction.

 

Section
7.05Entire Agreement. This Agreement and the documents to be delivered hereunder constitute the sole and entire agreement
of the parties to this Agreement with respect to the subject matter contained herein, and supersede all prior and contemporaneous
understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between
the statements in the body of this Agreement and the documents to be delivered hereunder, the Exhibits and Disclosure Schedules
(other than an exception expressly set forth as such in the Disclosure Schedules), the statements in the body of this Agreement
will control.

 

Section
7.06Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and permitted assigns. Neither party may assign its rights or obligations hereunder without the
prior written consent of the other party, which consent shall not be unreasonably withheld or delayed. No assignment shall relieve
the assigning party of any of its obligations hereunder.

 

Section
7.07No Third-party Beneficiaries. Except as provided in Article VI, this Agreement is for the sole benefit of the
parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or
shall confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or
by reason of this Agreement.

 

    	 	6	 

    	 

    

 

Section
7.08Amendment and Modification. This Agreement may only be amended, modified or supplemented by an agreement in writing
signed by each party hereto.

 

Section
7.09Waiver. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing
and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure,
breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring
before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from
this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy,
power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power
or privilege.

 

Section
7.10Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any
other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of Delaware.

 

Section
7.11Submission to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Agreement or the
transactions contemplated hereby may be instituted in the federal courts of the United States of America or the courts of the
State of Delaware, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or
proceeding.

 

Section
7.12Waiver of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Agreement
is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any
right it may have to a trial by jury in respect of any legal action arising out of or relating to this Agreement or the transactions
contemplated hereby.

 

Section
7.13Specific Performance. The parties agree that irreparable damage would occur if any provision of this Agreement were
not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms
hereof, in addition to any other remedy to which they are entitled at law or in equity.

 

Section
7.14Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of
which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail
or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy
of this Agreement.

 

[SIGNATURES
ON NEXT PAGE]

 

    	 	7	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.

 

	 	TURNAROUND
STRATEGIES, INC. 

	 	 
	 	By:	/s/
    Philip von Kahle
	 	Name:	Philip
    von Kahle
	 	Title:	Assignee

 

	 	ANYTHINGIT,
LLC 

	 	 
	 	By:	/s/
    David Bernstein
	 	Name:	David
    Bernstein
	 	Title:	Manager

 

    	 	8	 

    	 

    

 

Section
1.01 of Disclosure Schedule

 

	a locaetd at 17-09 Zink Place Unit 1, Fair Lawn NJ 07410
	 
	Manufacturer	 
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	warehouse supply	Stools
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Chairs
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Desks
	office furniture	Conference Table
	office furniture	Conference Table
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Tech Benches
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Rack
	uline	Rolling Bench
	uline	Rolling Bench
	uline	Rolling Bench
	uline	Rolling Bench
	uline	Rolling Bench
	uline	Rolling Bench
	Nissan	Forklift
	Garrett	Metal Detector
	Garrett	Metal Detector
	Vestil	Wrapping Machine
	Vestil	Scale
	SalterBrecknell	Scale
	Triner	Scale
	AmeriShred HDS	Shredder
	global	Banding Carts
	global	Banding Carts
	global	Banding Carts
	global	Power Pallet Jack
	global	Power Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	global	Manual Pallet Jack
	office furniture	Cubicle 4 unit
	office furniture	Cubicle 4 unit
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	File Cabinets
	office furniture	Credenza
	office furniture	Credenza
	office furniture	Credenza
	office furniture	Credenza
	office furniture	Credenza
	office furniture	Credenza

 

    	 	9	 

    	 

     

	IT Equipment	 	 	 	 
	 	 	BRAND	 	MODEL
	Desktop/Servers	 	Apple	 	PowerMac A1186
	 	 	HP	 	6200 Pro SFF
	 	 	HP	 	Z400 Workstation
	 	 	Apple	 	PowerMac A1186
	 	 	Apple	 	PowerMac A1186
	 	 	HP	 	6200 Pro SFF
	 	 	HP	 	Elite 8300 SFF
	 	 	HP	 	8100 Elite SFF
	 	 	HP	 	8100 Elite SFF
	 	 	HP	 	Z400 Workstation
	 	 	HP	 	Z400 Workstation
	 	 	HP	 	8100 SFF
	 	 	Dell	 	Optiplex 760
	 	 	Dell	 	Optiplex 748
	 	 	Dell	 	Optiplex 780
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 755
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 755
	 	 	Dell	 	Optiplex 755
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 745
	 	 	Dell	 	Optiplex 755
	 	 	Dell	 	Optiplex 745 SFF
	 	 	HP	 	dc7600 SFF
	 	 	Dell	 	Optiplex 745 SFF
	 	 	Dell	 	PowerEdge R710
	 	 	Diligiant	 	NAS
	 	 	HP	 	DL180G6
	 	 	Dell	 	PowerEdge R710
	 	 	HP	 	ProLiant DL360 G5
	 	 	HP	 	ProLiant DL360 G5
	 	 	HP	 	ProLiant DL360 G5
	 	 	HP	 	ProLiant DL320s
	 	 	Dell	 	R410
	 	 	Dell	 	R410
	 	 	Cisco	 	NAC Appliance 3390
	 	 	Dell	 	Optiplex 755
	 	 	Custom	 	Neat01
	 	 	Custom	 	Neat02
	 	 	Custom	 	Neat03
	 	 	Custom	 	Neat04
	 	 	Custom	 	Neat05
	 	 	Custom	 	Neat06
	 	 	Custom	 	Neat07
	 	 	Custom	 	Neat08
	Laptops	 	HP	 	Elite 6930P
	 	 	Lenovo	 	X201
	 	 	Dell	 	Latitude D630C
	 	 	Dell	 	X201
	 	 	Lenovo	 	X420
	 	 	Dell	 	Latitude D630C
	 	 	Dell	 	Latitude D630C
	 	 	Dell	 	Latitude 830
	Monitors	 	Dell	 	S2440L
	 	 	SamSung	 	SyncMaster BX2350
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	ViewSonic	 	VS12132
	 	 	ViewSonic	 	VS12132
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	Dell	 	2209WA
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	SamSung	 	SyncMaster 2233SW
	 	 	Dell	 	2208WFPt
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	Dell	 	2005FPW
	 	 	SamSung	 	SyncMaster 2243BWT
	 	 	Dell	 	2407WFPb
	 	 	Dell	 	2405FPw
	 	 	Dell	 	2405FPw
	 	 	Dell	 	G2410T
	 	 	HP	 	ZR22W
	 	 	HP	 	ZR22W
	 	 	Dell	 	1907FPc
	 	 	Dell	 	2407WFPL
	 	 	Dell	 	1908WFPt
	 	 	Dell	 	1908WFPt
	 	 	Dell	 	1908WFPt
	 	 	Nec	 	LCD1512
	 	 	Dell	 	1907FPI
	 	 	HP	 	ZR24W
	 	 	HP	 	LP2475W
	 	 	Dell	 	2007WFPb
	 	 	Dell	 	2009W
	 	 	Dell	 	1908WFPf
	 	 	Dell	 	1907FPt
	 	 	Nec	 	LCD2170NX-BK
	 	 	SamSung	 	SyncMaster 244T
	 	 	SamSung	 	SyncMaster 345BW
	 	 	Dell	 	1908WFPt
	 	 	HP	 	1740
	 	 	Dell	 	1907FPVt
	 	 	Dell	 	1707FPt
	 	 	Dell	 	2243BWT-I
	 	 	ViewSonic	 	V223W
	 	 	HP	 	L1950
	 	 	Dell	 	2047WFPb
	 	 	Dell	 	2007WFPb
	 	 	Dell	 	2208WPPb
	 	 	NEC	 	LCD1860NX
	 	 	ViewSonic	 	VS12512
	 	 	Dell	 	2405FPW
	 	 	Dell	 	1909W
	 	 	Dell	 	2007FPb
	 	 	Dell	 	2007FPb
	 	 	Dell	 	E151FP
	 	 	HP	 	TFT 7600 RKM
	 	 	Dell	 	1950FP
	 	 	SamSung	 	SyncMaster 2243BWFTAA1
	Network	 	Cisco	 	ws-c3750g-24ts-s
	 	 	Cisco	 	ws-c3750g-24ts-e
	 	 	Cisco	 	ws-c2960g-48tc-l
	 	 	Cisco	 	ws-c2950t-24
	 	 	Cisco	 	ws-c2960-24tt-l
	 	 	Cisco	 	ws-c2960-24t-l
	 	 	Cisco	 	ws-c2950t-24
	 	 	Cisco	 	ws-c2950t-24
	 	 	Cisco	 	air-ap1242ag-a-k9
	 	 	Linksys	 	wrt54g
	 	 	Linksys	 	wrt54gl
	 	 	Linksys	 	wrt54g
	 	 	Dell	 	PowerConnect 6224
	 	 	Cisco	 	ws-3750g-24ts-e
	 	 	Cisco	 	ws-3750g-24ts-e
	 	 	Cisco	 	air-ap1242ag-a-k9
	 	 	Cisco	 	air-ap1242ag-a-k9
	 	 	Cisco	 	air-ap1242ag-a-k9
	 	 	HP	 	ProCurve 2848(4904A)
	 	 	HP	 	ProCurve 2848(4904A)
	 	 	HP	 	ProCurve 2848(4904A)
	 	 	HP	 	ProCurve 2848(4904A)
	 	 	HP	 	ProCurve 2848(4904A)
	 	 	HP	 	ProCurve 2650(J4899C)
	 	 	Cisco	 	ws-c2960-24tt-l
	Printers	 	HP	 	LaserJet 4050N
	 	 	HP	 	LaserJet P2015dn
	 	 	HP	 	LaserJet 1320
	 	 	HP	 	LaserJet 1320
	 	 	Zebra	 	105SL
	 	 	HP	 	LaserJet P2015dn
	 	 	Dymo	 	LaserWriter 400
	 	 	Dymo	 	LaserWriter 400
	 	 	Zebra	 	ZP450
	 	 	HP	 	LaserJet 4100tn
	 	 	Zebra	 	105SL
	 	 	Dymo	 	LaserWriter 400
	 	 	Dymo	 	LaserWriter 400
	 	 	Dymo	 	LaserWriter 400
	 	 	HP	 	LaserJet P2015
	 	 	HP	 	LaserJet 4050TN
	 	 	HP	 	P2055dn
	 	 	Dymo	 	LaserWriter 400
	 	 	HP	 	LaserJet 4345mfp
	 	 	Dymo	 	LaserWriter 400
	 	 	Dymo	 	LaserWriter 400
	 	 	Dymo	 	LaserWriter 400
	UPS	 	Tripp Lite	 	SmartProUPS SMART3000RM2U/AGSM6908
	 	 	Tripp Lite	 	SmartProUPS SMART3000RM2U/AGSM6908
	 	 	Tripp Lite	 	SmartProUPS SMX2200XLRT2U/AGSM7145
	 	 	APC	 	SmartUPS 2200
	 	 	APC	 	SmartUPS 2200
	Hvac	 	Denso	 	MovinCool 15SFU-1
	 	 	Air-Con	 	Ductless AC A13EM4H4G12/A13CH4H4G12, A13CH4H4G12(compressor)
	 	 	Danby	 	DPA80A1CB
	 	 	TOYOTOMI	 	TID-1800
	 	 	HoneyWell	 	HEPA Air Purifier 50250-S
	Handhelds	 	Symbol	 	MC9063
	 	 	Symbol	 	MC9063
	 	 	Symbol	 	MC9063
	 	 	Motion Computing	 	MC-C5
	 	 	Motion Computing	 	MC-C5
	 	 	Motion Computing	 	MC-C5
	Phones	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	 	 	Cisco	 	CP-7960G
	Misc	 	Panasonic	 	TH-42PWD8
	 	 	HP	 	Digital Sender 9250C
	 	 	Compaq	 	Storage Works Ultrium 960
	 	 	TrendNet	 	KVM Switch TK-1603R
	 	 	TrendNet	 	KVM Switch TK-1603R
	 	 	TrendNet	 	KVM Switch TK-1603R
	 	 	TrendNet	 	KVM Switch TK-1603R
	 	 	Dell	 	KVM Switch 1016-003

 

    	 	10	 

    	 

     

	WeedHire Trademark	Registration Number 4783237	 	 	 
	**BE ADVISED We do not own the domain name weedhire.com	 	 	 	 	 
	anythingit.com domain	 	 	 	 	 	 
	ANYTHINGIT Trademark	Serial Number	Reg.

Number	Word 

Mark	Check

Status	Live/Dead	 
	 	1	78959935	3318296	ANYTHINGIT	TSDR	LIVE
	 	2	78928734	3329420	ANYTHINGIT	TSDR	LIVE

 

    	 	11	 

    	 

    

 

Section
1.02 of Disclosure Schedule

 

	Name	 	Amount	 
	92 ROUTE 46 ASSOCIATESLLC	 	$	468,750.00	 
	AXIS GLOBALS-V	 	$	6,427.19	 
	CFO ON CALL	 	$	3,995.00	 
	QUICK INTERNATIONAL	 	$	10,742.23	 
	WELLS FARGO-Forklift	 	$	6,600.88	 
	WELLS FARGO-Racking	 	$	1,003.63	 
	GE capital-copier	 	$	3,057.45	 
	BANKDIRECT CAPITAL FINANCE, LLC.	 	$	3,271.00	 
	FAI	 	$	34,490.50	 
	MicroTch	 	$	51,580.00	 
	ULLINK	 	$	29,000.00	 
	 	 	 	 	 
	 	 	$	618,917.88	 

 

    	 	12Exhibit
4.11

 

SignPath
Pharma Inc.

 

Investor
Subscription Documents

 

A
Private Offering to Accredited Investors

 

 

 

	 	March
    8, 2016

 

	 	I.	Subscription
    and Payment Instructions 
	 	 	 
	 	II.	Purchaser
    Questionnaire and Statement***
	 	 	 
	 	III.	Form
    of Subscription Agreement***

 

Private
Placement Memorandum

 

Exhibit
A – Certificate of Designation of Series E Preferred Stock

 

Exhibit
B – Form of Class E Warrant

 

Exhibit
C – Annual Report on Form 10-K for December 31, 2014

 

Exhibit
D – Quarterly Report on Form 10-Q for September 30, 2015

 

***
To be completed and executed by Investor and returned to Meyers Associates, L.P., Inc., as provided below.

 

THE
ENCLOSED DOCUMENTS RELATE TO A PRIVATE PLACEMENT OF SECURITIES BY SIGNPATH PHARMA INC. THE SECURITIES THAT ARE THE SUBJECT OF
THE ENCLOSED SUBSCRIPTION DOCUMENTS ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK AND SHOULD NOT BE PURCHASED BY ANYONE WHO
CANNOT AFFORD THE LOSS OF HIS, HER OR ITS ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD CAREFULLY REVIEW THE ENCLOSED DOCUMENTS.

 

    	 	 	 

     

    

 

ITEM
I

 

SUBSCRIPTION
INSTRUCTIONS

 

	1.	Complete the Purchaser Questionnaire and Statement unless previously completed (Item II
    in this Package).
	 	 
	2.	Complete the Subscription Agreement by signing the signature page as follows:
	 	 
	 	1.1 If the Investor
    is an individual sign over the line “Signature of Investor”. If there is a second individual Investor (not a partnership),
    that person should sign on “Co-Investor” line.
	 	 
	 	1.2 If the Investor
    is not an individual, an authorized signatory of the entity should sign under the line “If Entity Investor” and
    fill in the requested information.
	 	 
	 	1.3 Print the Investor’s
    name and mailing address where indicated on the signature page.
	 	 
	3.	Send in your payment following these PAYMENT INSTRUCTIONS:
	 	 
	 	Send the funds for your participation either by wire transfer or by check in accordance with
    the following instructions:

 

	 	—
    Wire Funds	 	Wire
    the funds to SignPath Pharma Inc. to the following account:
	 	 	 	 
	 	 	 	Capital
    One Bank
	 	 	 	57
    West 57th Street
	 	 	 	New
    York, New York 10019
	 	 	 	For
    the Account of Davidoff Hutcher & Citron LLP
	 	 	 	Reference:
    SignPath Pharma Inc. 
	 	 	 	IOLA
    Attorney Trust Account
	 	 	 	ABA
    Routing No. 021407912
	 	 	 	Account
    No. 7047522050 
	 	 	 	 
	 	—
    Check	 	Make
    your check payable to “DAVIDOFF HUTCHER & CITRON LLP, as Escrow Agent for SIGNPATH PHARMA INC.” and:

 

RETURN
CHECK AND ALL COMPLETED AND SIGNED MATERIALS TO: 

 

	 	Meyers
    Associates, L.P.
	 	45
    Broadway
	 	New
    York, NY 10006
	 	Attn:
    Ms. Eileen Slitkin

 

THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND ARE BEING OFFERED AND SOLD ONLY TO ACCREDITED
INVESTORS IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE ACT. SUCH SECURITIES MAY NOT BE REOFFERED FOR
SALE OR RESOLD OR OTHERWISE TRANSFERRED UNLESS THEY ARE REGISTERED UNDER THE APPLICABLE PROVISIONS OF THE ACT OR ARE EXEMPT FROM
SUCH REGISTRATION.

 

    	 	 	 

     

    

 

ITEM
II

 

SIGNPATH
PHARMA INC.

 

PURCHASER
QUESTIONNAIRE AND STATEMENT

 

THIS
QUESTIONNAIRE IS TO BE COMPLETED AND DELIVERED TO MEYERS ASSOCIATES, L.P. PRIOR TO ACCEPTANCE OF THE SUBSCRIPTION BY THE COMPANY,
CERTAIN CONDITIONS MUST BE MET.

 

INSTRUCTIONS:
This Questionnaire, along with the attached Subscription Agreement, is being provided to each individual (or entity) who has expressed
an interest in purchasing units (“Units”), consisting of shares of convertible preferred stock (“Preferred
Stock”) and warrants to purchase common stock (“Warrant”) of SignPath Pharma Inc. (the “Company”).
Prior to your acceptance by the Company as a subscriber, you must meet, among other requirements, the standards imposed by Regulation
D, and/or Regulations S as adopted by the Securities and Exchange Commission under the Securities Act of 1933, as amended (the
“Securities Act”), since the Units have not been registered under the Securities Act and are being sold in
reliance upon the exemption provided by Section 4(a)(2) of the Securities Act and Rule 506 or Rule 903 promulgated thereunder.
The Company has established general investor suitability requirements for all investors requiring that each natural person or
entity who subscribes for Units must be an “accredited investor,” as such term is defined in Regulation D under the
Securities Act. The undersigned acknowledges and agrees that the Company is relying on the undersigned’s representations
contained in this Questionnaire and the related Subscription Agreement in determining whether to accept the subscription.

 

Please
contact Elliot H. Lutzker, counsel to the Company, at Davidoff Hutcher & Citron LLP, 605 Third Avenue Avenue, 34th
Floor, New York, New York 10158, (646) 428-3210, if you have any questions in completing this Questionnaire.

 

If
your answer to any question is “none” or “not applicable,” please so state.

 

Your
answers will, at all times, be kept strictly confidential; however, everyone who agrees to purchase the Units hereby agrees that
the Company may present this Questionnaire to such parties as they deem appropriate in order to assure themselves that the offer
and sale of the Units to you will not result in a loss of the exemption from registration under the Securities Act, which is being
relied upon by the Company in connection with the sale of the Units.

 

Please
complete this Questionnaire as thoroughly as possible and sign, date and return one copy. In case of insufficient space, please
attach additional pages, as needed, to assure that complete answers are submitted.

 

    	 	 	 

     

    

 

Please
print or type:

 

	1.	NAME(S)
    IN WHICH UNITS ARE TO BE HELD:
	 	 	 	 	 
	 	A.	 	 	 
	 	 	 	 	 
	 	 	First
    Name	Initial	Last
    Name
	 	 	 	 	 
	 	B.	 	 	 
	 	 	 	 	 
	 	C.	 	 	 
	 	 	 	 	 
	 	 	Entity	 	 
	 	 	 	 	 
	 	 	(if
    a husband and wife are purchasing the Units, please give the name of both the husband and the wife.)

 

	2.	SOCIAL
    SECURITY NUMBER(S) or TAX IDENTIFICATION NUMBER(S):
	 	 	 	 	 

	 	A.	 	 	 	 
	 	 	 	 	 	 
	 	B.	 		 	 
	 	 	 	 	 	 
	 	C.	 	 	 	 

 

	3.	MANNER
    IN WHICH TITLE TO BE HELD (Please Check One):	 
	 	 	 	 	 
	 			Individual
    Ownership	 
	 	 	 	 	 
	 			Community
    Property 	 
	 	 	 	 	 
	 			Tenants
    in Common 	 
	 	 	 	 	 
	 			Joint Tenants with Rights of Survivorship 	 
	 	 	 	 	 
	 			Partnership 	 
	 		 	 	 
	 			Corporation 	 
	 	 	 	 	 
	 			As
    Custodian, Executor or Trustee for _________________________	 

 

FOR
INDIVIDUAL INVESTORS: 

 

	4.	Residential
    Address, Telephone Number and Email Address:
	 	 
	 	 
	 	 
	 	 
	 	  

 

    	 	-2-	 

    	 

    

 

	 	Date
    of Birth: (A) __________________		(B)
    ________________	 
	 	 	 	 	 
	 	Occupation:
    (A) __________________		(B)
    ________________ 	 
	 	 	 	 	 
	 	Position:
    (A) ____________________		(B)
    ________________ 	 
	 	 	 	 	 
	 	Business
    Address and Telephone Number:	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 		 
	 	 	 	 	 
	 	Person
    or Persons to be Contacted at Place of Employment:	 	 
	 	 	 
	 		 
	 	 	 
	 	Bank
    or Banks at which Checking and/or Savings Accounts are located:	 

 

	 	Name
    or Names of Banks:	 		 

	 	 	 	 	 	 	 
	 	Branch	 		 	Address:	

	 	 	 	 	 
	 	or
    Addresses	 	 	 

	 	 	 	 	 
	 	Persons
    at Bank or Banks to Contact and Telephone Number:	 

	 	 	 	 	 
	5.	In
    Which State Do You Currently:	 	 
	 	 	 	 	 
	 	A.	Maintain
    your primary residence?		

	 	 	 	 	 
	 	B.	Maintain
    secondary residence, if any?		 

	 	 	 	 	 
	 	C.	Vote?		 

	 	 	 	 	 
	 	D.	File
    income tax returns?		 

	 	 	 	 	 
	 	E.	Maintain
    a driver’s license?		 

	 	 	 	 	 
	 	Number
    of years at primary residence listed above?			

	 	 	 	 	 
	6.	Accredited
    Investor Certification.	 	 	 
	 	 	 	 	 
	 	Please
    INITIAL where appropriate:	 	 	 

	 	 	 
	 	A.	_____
    I certify that I have a net worth (excluding primary residence) of at least $1 million either individually or through aggregating
    my individual holdings and those in which I have a joint, community property or other similar shared ownership interest with
    my spouse.

 

    	 	-3-	 

    	 

    

 

The
above net worth takes into account my current assets and other assets diminished by my current liabilities and other liabilities
including contingent liabilities, such as threatened or pending lawsuits and proceedings.

 

	 	B.	_____
    I certify that I have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my
    spouse) and expect my income (or joint income, as appropriate) to reach the same level in the current year.
	 	 	 
	 	C.	_____
    I certify that I am a director or executive officer of the Company.
	 	 	 
	 	D.	I
    am aware that the proposed offering of the Units will involve non-marketable, non-transferable securities requiring my capital
    investment to be maintained for an indefinite period of time.

 

	Yes
    ________	No
    ________

 

	7.	Please
    indicate whether you are a director, officer, employee, owner of an interest in or an “affiliate” of any securities
    brokerage firm which is a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”). (An “affiliate,”
    as defined in Rule 405 of the Securities Act, means one who directly or indirectly, through one or more intermediaries, controls
    or is controlled by or is under common control with such person.)

 

	Yes
    ________	No
    ________

 

If
yes, please state the firm name and address and describe your relationship.

 

	 	 
	 	 
	 	 

 

	8.	Investment
    experience:
	 	 
	 	(a)	The
    frequency with which you invest in marketable securities is:
	 	 	 
	 	 	(
    ) often ( ) occasionally ( ) never
	 	 	 
	 	(b)	The
    frequency with which you invest in unmarketable securities (such as private placement offerings) is:
	 	 	 
	 	 	(
    ) often ( ) occasionally ( ) never
	 	 	 
	 	€	Have
    you previously participated in private placement offerings in the last 5 years?

 

	________	________ 
	 	 
	Yes	No

 

    	 	-4-	 

    	 

    

 

	 	(d)	If
    you answered “yes”€(c) above, state the private placements in which you participated in the last 5 years.

 

	Year	 	Amount Invested	 	 	Name of Issuer
	2015	 	$	 	 	 	 
	2014	 	$	 	 	 	 
	2013	 	$	 	 	 	 
	2012	 	$	 	 	 	 
	2011	 	$	 	 	 	 

 

	 	(e)	Have
    you been afforded an opportunity to investigate the Company and review relevant factors and documents pertaining to the officers,
    directors and the Company and its business and to ask questions of a qualified representative of the Company regarding this
    investment and the properties, operations, and methods of doing business of the Company?

 

	________	________
	 	 
	Yes	No

 

	 	(f)	Do
    you understand the nature of an investment in the Company and the risk associated with such an investment? 

 

	________	________
	 	 
	Yes	No

 

	 	(g)	Do
    you understand that there is no guarantee of any financial return on this investment?

 

	________	________
	 	 
	Yes	No

 

	 	(h)	Do
    you understand that this investment is not liquid?

 

	________	________
	 	 
	Yes	No

 

    	 	-5-	 

    	 

    

 

	 	(i)	Do
    you have adequate means of providing for your current needs and personal contingencies in view of the fact that this is not
    a liquid investment?

 

	________	________
	 	 
	Yes	No

 

	 	(j)	Are
    you aware of the Company’s business affairs and financial condition, and have you acquired all such information about
    the Company as you deem necessary and appropriate to enable you to reach an informed and knowledgeable decision to acquire
    Securities?

 

	________	________
	 	 
	Yes	No

 

	9.	What
    was your individual (or joint, if you filed a joint tax return) federal marginal tax bracket (the highest rate taxed) for
    the last three years? Check one box for each year.

 

	If
    Taxable Income is:	over
    $100,000 up to $335,000	over
                                         $75,000 up to $100,000
	over
    $50,000 up to $75,000
	 	 	 	 
	 	Tax
    Bracket is:	Tax
    Bracket is:	Tax
    Bracket is:
	 	 	 	 
	2015	39%
    [  ]	34%
    [  ]	25%
    [  ]
	 	 	 	 
	2014	39%
    [  ]	34%
    [  ]	25%
    [  ]
	 	 	 	 
	2013	39%
    [  ]	34%
    [  ]	25%
    [  ]

 

	10.	What
    are your personal investment objectives?

 

	 
	 
	 

 

	11.	FINRA
    Affiliation. Please state whether you or any of your associates or affiliates (which includes your spouse, in-laws and children
    or parents): (i) are a member or a person associated (including as an employee, officer, director, partner) with a member
    of FINRA, (ii) are an owner of stock or other securities of an FINRA member, (iii) has made a subordinated loan to any FINRA
    member, or (iv) a relative or member of the same household of any person meeting the description set forth in clauses (i)
    through (iii) above.

 

	_______	_______
	 	 
	Yes	No

 

    	 	-6-	 

    	 

    

 

If
you marked yes above, please briefly describe the FINRA relationship below:

 

	 
	 
	 
	 
	 

 

	12.	Please
                                         state how your first learned about the Company and how you learned about this Offering.

 

	 	 
	 	 
	 	 
	 	 
	 	 

 

	13.	Please
                                         provide in the space below any additional information which would evidence that you have
                                         sufficient knowledge and experience in financial and business matters so that you are
                                         capable of evaluating the merits and risks of investing in non-transferable, restricted
                                         securities of a corporate entity.

 

	 	 
	 	 
	 	 
	 	 
	 	 

 

IF
YOU ARE PURCHASING SECURITIES WITH YOUR SPOUSE, YOU MUST BOTH SIGN THE SIGNATURE PAGE.

 

IF
YOU ARE PURCHASING SECURITIES WITH ANOTHER PERSON NOT YOUR SPOUSE, YOU MUST EACH FILL OUT A SEPARATE INDIVIDUAL QUESTIONNAIRE.

 

    	 	-7-	 

    	 

    

 

FOR
CERTAIN QUALIFIED ORGANIZATIONS:

 

	1.	Additional
    information for corporate, partnership, LLC or trust subscribers:

 

	 	A.	Name
    of organization or entity:	 

 

	 	B.	Business
    address:	 

 

	 	C.	Telephone:
    (_____)	 

 

	 	D.	Send
    communications to the attention of:	 

 

	 	E.	Date
    of organization:	 

 

	 	F.	State
    of organization:	 

 

	 	G.	Tax
    identification no.:	 

 

	 	H.	Form
    of organization:	 

 

	 	Corporation	 	 	Partnership	 	 	LLC	 

 

	 	Trust
    	 	 	Other
    (Describe) 	 	 

 

	 	 
	 	 
	 	 

 

	 	I.	If
    a corporation, the organization has _____ has not _____ elected to be taxed as a small business corporation for federal income
    tax purposes under the provisions of Subchapter S of the Internal Revenue Code of 1986, as amended.
	 	 	 
	 	J.	The
    organization is actively engaged in the conduct of a trade or business:

 

	Yes
    ________	No
    ________

 

	 	K.	Describe
    purpose of formation or principal trade or business activity:

 

	 	 
	 	 
	 	 

 

	 	L.	Was
    such entity formed for the purpose of purchasing the Units?

 

	Yes
    ________	No
    ________

 

    	 	-8-	 

    	 

    

 

	2.	The
    corporate, partnership, limited liability company or trust subscriber represents and warrants that it is (check one):

 

_______a.
A corporation, partnership, Massachusetts or similar business trust, or organization described in Section 501(c)(3) of the Internal
Revenue Code (tax exempt organization), not formed for the specific purpose of acquiring the Units, having total assets in excess
of $5,000,000.

 

_______b.
A bank, savings and loan association or other similar institution (as defined in Sections 3(a)(2) and 3(a)(5)(A) of the Securities
Act).

 

_______c.
An insurance company (as defined in Section 2(13) of the Securities Act).

 

_______d.
An investment company registered under the Investment Company Act of 1940.

 

_______e.
A business development company (as defined in Section 2(a)(48) of the Investment Company Act of 1940) or a private business development
company (as defined in Section 202(a)(22) of the Investment Advisers Act of 1940).

 

_______f.
A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
Business Investment Act of 1958.

 

_______g.
A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended.

 

_______h.
A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, which plan has total assets in excess of $5,000,000.

 

_______i.
An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision
is made by a “Plan Fiduciary,” as defined in Section 3(21) of such Act, which is either a bank, savings and loan association,
insurance company or registered investment advisor.

 

_______j.
An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 having total assets in excess
of $5,000,000.

 

_______k.
A self-directed employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, with investment
decisions made solely by persons who are accredited investors as defined in Rule 501(a) of Regulation D.

 

_______l.
A trust with total assets in excess of $5,000,000 not formed for the specific purpose of acquiring the Units offered, whose purchase
is directed by a sophisticated person (i.e., a person who has such knowledge and experience in financial and business matters
that he is capable of evaluating the merits and risks of an investment in the Units).

 

_______m.
An entity in which all of the equity owners are accredited investors as defined in Rule 501(a) of Regulation D. (If subsection
m. is checked, each equity owner must complete an investor questionnaire).

 

    	 	-9-	 

    	 

    

 

	3.	Please
    provide the following:

 

(1)
If an S Corporation, the names of all officers, directors, and stockholders.

 

(2)
If a partnership, the names of all partners indicating whether each person is a general partner or limited partner.

 

(3)
Financial statements of corporate or partnership subscriber, accompanied by a certificate of an officer or general partner.

 

For
each class of investor listed on the following page, this signed Questionnaire must be accompanied by the following verification
documents:

 

CORPORATE
SUBSCRIBER

 

A
certified copy of a resolution of the corporation’s board of directors: (i) designating the officer(s) of the corporation
authorized to sign on behalf of the corporation; and (ii) authorizing the contemplated investment.

 

PARTNERSHIP
AND LLC SUBSCRIBER

 

A
certificate signed by all the general partners or managing members authorizing the general partner or managing member who signed
the signature page on behalf of the partnership or LLC to sign and to make the contemplated investment on behalf of the partnership
or LLC.

 

TRUST
SUBSCRIBER

 

A
certificate signed by all the trustees authorizing the trustee who signed the signature page on behalf of the trust to sign and
to make the contemplated investment on behalf of the trust.

 

CUSTODIAN
SUBSCRIBER

 

A
certified copy of the instrument pursuant to which the custodian is acting.

 

[Signature
page follows]

 

    	 	-10-	 

    	 

    

 

I
consent to the communication by the Company, or any of its employees, agents and affiliates with any bank or business reference
set forth above.

 

The
foregoing statements are true and accurate to the best of my information and belief, and I will notify the Company of any change
in the foregoing answers.

 

	FOR
    INDIVIDUAL SUBSCRIBERS(S)	 	FOR
    CORPORATE, PARTNERSHIP, LLC OR TRUST SUBSCRIBERS
	 	 	 
	 	 	 
	Name
    of Subscriber [Please Print]	 	Name
    of Subscriber [Please Print]
	 	 	 
	 	 	 
	Signature	 	Authorized
    Signatory

 

	(B)	 	 	 
	 	Name
    of Subscriber [Please Print]	 	Name
    and Title of Authorized Signatory [Please Print]
	 	 	 
	 	 	 
	Signature	 	 

 

	Date
    and Place of Execution:	 	 
	 	 	 
	Date:	 	 	Place:	 

 

[Signature
Page to Investor Questionnaire]

 

    	 	-11-	 

    	 

    

 

EXHIBIT
4.11

 

ITEM III

 

SUBSCRIPTION
AGREEMENT

 

This
Subscription Agreement (this “Agreement”),
dated as of March 8, 2016, by and among SignPath Pharma Inc., a Delaware corporation (the “Company”), and each
subscriber identified on the signature page hereto (each a “Subscriber” and collectively the “Subscribers”).

 

Whereas,
the Company proposes to offer for sale in a private placement solely to selected institutional and retail “accredited investors”
and/or “Non-U.S. Persons” (the “Offering”), up to $3,000,000 of units (“Units”),
with an over-subscription option for $2,000,000 at $1,000 par value each Unit, consisting of one share of the Company’s
Series E Convertible Preferred Stock, $.10 par value (“Preferred Stock”), convertible at $2.00 per share, for
an aggregate of 500 shares of Common Stock and Class E warrants (the “Warrant”) to purchase 125 shares of Common
Stock, at $3.00 per share, pursuant to the terms and conditions set forth herein (the Units, Preferred Stock, Warrants and the
Underlying Shares (as defined herein) are collectively referred to herein as the “Securities”), and the Subscriber
desires to acquire the number of Units set forth on the signature page hereof. The Minimum Subscription is $100,000 (however,
the Company and Meyers Associates, L.P. (the “Placement Agent”) may accept lesser subscriptions at their sole
discretion.

 

Whereas,
the terms of the Securities offered hereby are set forth under the heading “Description of Securities” in the Company’s
Confidential Private Placement Memorandum dated the date hereof (the “Memorandum”);

 

Whereas,
Meyers Associates, L.P. is acting as Placement Agent for the Offering pursuant to the terms and conditions of a placement agency
agreement (the “Agency Agreement”) by and between the Company and the Placement Agent;

 

Whereas,
the Subscriber is delivering simultaneously herewith,
unless previously submitted, a completed confidential purchaser questionnaire (the “Questionnaire”);

 

Whereas,
the Company and the Subscribers are executing and delivering this Agreement in reliance upon an exemption from securities registration
afforded by the provisions of Section 4(a)(2), Regulation D (“Regulation D”), and/or Regulation S (“Regulation
S”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities
Act of 1933, as amended (the “1933 Act,” collectively the “Offering Exemption”);

 

Now,
Therefore, in consideration of the mutual
covenants and other agreements contained in this Agreement, the Company and the Subscribers hereby agree as follows:

 

1.
Purchase and Sale of Units. Subject to the satisfaction of the terms and conditions of this Agreement, each Subscriber
hereby irrevocably agrees to purchase the full number of Units in the amount designated on the signature page hereto (the “Subscription
Amount”) at the Unit Purchase Price, and the Company shall sell such Units to such Subscribers at the Unit Purchase
Price.

 

    	 	 	 

    	 

    

 

2.
Escrow Arrangements; Form of Payment. Upon execution of this Agreement by the parties and pursuant to the terms of the
escrow agreement (the “Escrow Agreement”) entered into between the Company, the Placement Agent and Davidoff
Hutcher & Citron LLP (the “Escrow Agent”), each Subscriber agrees to make the deliveries required of it
as set forth herein and in the Escrow Agreement, and the Company agrees to make the deliveries required of it as set forth herein
and in the Escrow Agreement. The Subscriber acknowledges and agrees that all subscription amounts will be placed in a non-interest
bearing escrow account pending the Closing.

 

3.
Terms of the Securities.

 

(a)
Each Warrant shall be in the form attached to the Memorandum as Exhibit B, and will be subject to the terms and conditions
contained therein; and

 

(b)
Each share of Preferred Stock will be subject to the terms and conditions contained in the Certificate of Designations in the
form attached to the Memorandum, as Exhibit A, and will be subject to the terms and conditions contained therein.

 

4.1
Closing. At the closing of the transactions contemplated herein (the “Closing”), the Subscribers shall
purchase, severally and not jointly, and the Company shall issue and sell, in the aggregate, a maximum of $3,000,000 of Units,
with a $2,000,000 over-subscription. Each Subscriber shall purchase from the Company, and the Company shall issue and sell to
each Subscriber, the amount of Units specified on the signature page hereto. Upon satisfaction of the conditions set forth in
Section 4.2 a closing (the “Closing”) will be held as soon as practicable. All additional funds held in escrow
and not accepted by the Company shall be returned to Subscribers without interest or deduction. The Closing shall occur, from
time to time, on the dates that subscriptions have been received and accepted by the Company and the Placement Agent at the offices
of Davidoff Hutcher & Citron LLP, 605 Third Avenue, 34th Floor, New York, New York 10158, or such other time and/or
location as the parties shall mutually agree. At each Closing, the conditions of Section 4.2 shall either be satisfied or waived
by the appropriate parties. 

 

4.2
Closing Conditions.

 

(a)
Each Subscriber’s obligations at each Closing are conditioned upon the Company’s fulfillment (or waiver by the Subscriber
in its sole discretion) of each of the following events as of the date of each such Closing and the Company’s delivery to
such Subscriber and the Placement Agent of:

 

(i)
this Agreement duly executed by the Company;

 

(ii)
a certificate evidencing ownership of a number of shares of Preferred Stock equal to such Subscriber’s Subscription Amount;
and

 

(iii)
a Warrant, registered in the name of such Subscriber, pursuant to which such Subscriber shall have the right to acquire, a number
of shares of Common Stock equal to one-fourth the number of shares of Common Stock issuable upon conversion of Preferred Stock
included in a Unit.

 

    	 	-2-	 

    	 

    

 

(b)
The Company’s obligations at each Closing are conditioned upon each Subscriber’s delivery to the Company of the following:

 

(i)
this Agreement duly executed by such Subscriber;

 

(ii)
readily available funds, deposited and cleared in the escrow account contemplated by the Escrow Agreement, in an amount sufficient
to purchase the Subscription Amount; and

 

(iii)
an executed and properly completed Questionnaire if not previously provided.

 

(c)
The representations and warranties of the parties set forth in this Agreement shall be true and correct in all material respects
as of each Closing Date as if made on such date (except that to the extent that any such representation or warranty relates to
a particular date, in which case such representation or warranty shall be true and correct in all material respects as of that
particular date); and

 

(d)
At each Closing Date, there shall have occurred no material adverse change in the Company’s consolidated business or financial
condition since September 30, 2015, except as set forth in the Offering Documents (as defined below).

 

5.
Subscriber’s Representations and Warranties. Each Subscriber hereby represents and warrants as of the date hereof
and as of the Closing, with regard to itself that:

 

(a)
Reliance on Exemptions. The Subscriber acknowledges that the Offering has not been reviewed by the SEC or any state agency
because it is intended to be a nonpublic offering exempt from the registration requirements of the 1933 Act and state securities
laws. The Subscriber understands that the Company is relying in part upon the truth and accuracy of, and the Subscriber’s
compliance with, the representations, warranties, agreements, acknowledgements and understandings of the Subscriber set forth
herein in order to determine the availability of such exemptions and the eligibility of the Subscriber to acquire the Units. 

 

(b)
Information on Subscriber. The Subscriber is, and will be at the time of the exercise of the Warrants, an “accredited
investor” as defined in Section 2(a)(15) of the 1933 Act and Rule 501 of Regulation D promulgated thereunder, or
a Non-U.S. Person, as defined in Rule 902 of Regulation S promulgated thereunder. Such Subscriber is not required to be registered
as a broker-dealer under Section 15 of the 1934 Act, is experienced in investments and business matters, has previously made investments
of a speculative nature, understands that an investment in the Securities involves a high degree of risk, has purchased securities
of United States companies in private placements in the past and, with its representatives, has such knowledge and experience
in financial, tax and other business matters as to enable the Subscriber to utilize the information made available by the Company
to evaluate the merits and risks of and to make an informed investment decision with respect to the proposed purchase, which represents
a speculative investment. The Subscriber, if not a natural person, has the necessary authority to and is duly and legally qualified
to purchase and own the Securities. If the Subscriber is natural person, he or she has reached the age of majority in the state
in which the Subscriber resides, has adequate means of providing for the Subscriber’s current needs and personal contingencies
and is able to bear the risk of such investment for an indefinite period and to afford a complete loss thereof. The information
set forth on the signature page hereto and in such Subscriber’s Questionnaire regarding the Subscriber is accurate. The
sale of the Securities to the Subscriber as contemplated in this Agreement complies with or is exempt from the applicable securities
legislation of the jurisdiction of the residence of the Subscriber.

 

    	 	-3-	 

    	 

    

 

(c)
Investment Purpose. At Closing, the Subscriber will purchase the Units for its own account for investment purposes only
and not as a nominee or agent and not with a view towards or for resale in connection with the distribution of the Securities.

 

(d)
Risk of Involvement. The Subscriber recognizes that the purchase of the Units involves a high degree of risk in that: (i)
an investment in the Company is highly speculative and only investors who can afford the loss of their entire investment should
consider investing in the Company and the Securities; (ii) transferability of the Securities is limited; and (iii) the Company
may require substantial additional funds to operate its business and there can be no assurance that the Offering will be completed
or that any other funds will be available to the Company, in addition to all of the other risks set forth in the Company’s
Memorandum.

 

(e)
Information. The Subscriber acknowledges careful review of: (i) the Memorandum; (ii) this Agreement; and (iii) all exhibits,
schedules and appendices which are part of the aforementioned documents (collectively, the “Offering Documents”),
and hereby represents that: (A) the Subscriber has been furnished by the Company during the course of this transaction with all
information regarding the Company which it has requested; (B) that the Subscriber has been afforded the opportunity to ask questions
of and receive answers from duly authorized officers of the Company concerning the terms and conditions of the Offering; and (C)
the Subscriber, if it has requested, has been given the opportunity by the Placement Agent to review the Agency Agreement.

 

(f)
Compliance with Securities Act. The Subscriber understands and agrees that the Securities are “restricted securities”
that have not been registered under the 1933 Act or any applicable state securities laws, by reason of their issuance in a transaction
that does not require registration under the 1933 Act (based in part on the accuracy of the representations and warranties of
Subscriber contained herein), and that such Securities must be held indefinitely unless a subsequent disposition is registered
under the 1933 Act or any applicable state securities laws or is exempt from such registration.

 

(g)
No Representations. The Subscriber hereby represents that, except as expressly set forth in the Offering Documents, no
representations or warranties have been made to the Subscriber by the Company or any agent, employee or affiliate of the Company,
including the Placement Agent, and in entering into this transaction the Subscriber is not relying on any information other than
that contained in the Offering Documents and the results of independent investigation by the Subscriber. The Subscriber has conducted
its own due diligence of the Company and is not relying on the Placement Agent’s diligence.

 

    	 	-4-	 

    	 

    

 

(h)
Transfer or Resale. The Subscriber acknowledges that there is no public market for any of the Company’s securities.
The Subscriber understands that Rule 144 (the “Rule”) promulgated under the 1933 Act requires, among other
conditions, a six-month holding period prior to the resale (in limited amounts) of securities of a reporting issuer acquired in
a non-public offering without having to satisfy the registration requirements under the 1933 Act. The Subscriber understands and
hereby acknowledges that the Company is under no obligation to register the Common Stock under the 1933 Act covering the resale
of the shares of Common Stock into which the Preferred Stock are convertible and into which the Warrants are exercisable (together,
the “Underlying Shares”) which were purchased by the Subscriber pursuant to this Agreement. The Subscriber
consents that the Company may, if it desires, permit the transfer of the Securities out of the Subscriber’s name only when
the Subscriber’s request for transfer is accompanied by an opinion of counsel reasonably satisfactory to the Company that
neither the sale nor the proposed transfer results in a violation of the 1933 Act or any applicable state “blue sky”
laws.

 

(i)
No Hedging Transactions. The Subscriber hereby agrees not to engage in any Hedging Transaction (as defined herein) until
such time as the Underlying Shares, as applicable, have been registered for resale under the 1933 Act or may otherwise be sold
in the public market without an effective registration statement under the 1933 Act. “Hedging Transaction” means any
short sale (whether or not against the box) or any purchase, sale or grant of any right (including, without limitation, any put
or call option) with respect to any security (other than a broad-based market basket or index) that includes, relates to or derives
any significant part of its value from the Company’s Common Stock or any rights, warrants, options or other securities that
are convertible into, or exercisable or exchangeable for, Common Stock.

 

(j)
Preferred Stock Legend. The Preferred Stock issued hereunder shall bear the following or similar legend:

 

NEITHER
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE INTO HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY,
MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO SOCIAL REALITY, INC. (THE “COMPANY”)
THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

    	 	-5-	 

    	 

    

 

PURSUANT
TO SECTION 151(f) OF THE DELAWARE GENERAL CORPORATION LAW, THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH STOCKHOLDER WHO SO
REQUESTS, A FULL STATEMENT OF THE DESIGNATIONS, POWERS, PREFERENCES AND RELATIVE, PARTICIPATING, OPTIONAL OR OTHER SPECIAL RIGHTS
OF EACH CLASS OF SHARES OR SERIES THEREOF OF THE COMPANY, AND QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES
AND/OR RIGHTS. SUCH REQUEST MAY BE MADE TO THE CORPORATION OR TO THE TRANSFER AGENT.

 

(k)
Warrants Legend. The Warrants shall bear the following or similar legend:

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR REASONABLY ACCEPTABLE TO THE COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE
REASONABLY ACCEPTABLE TO SOCIAL REALITY, INC.

 

(l)
Communication of Offer. The offer to sell the Securities was directly communicated to the Subscriber by the Company or
the Placement Agent or any selling group member. At no time was the Subscriber presented with or solicited by any leaflet, newspaper
or magazine article, radio or television advertisement, or any other form of general advertising, or solicited or invited to attend
a promotional meeting otherwise than in connection and concurrently with such communicated offer and did not learn of the Offering
or the Company by way of a registration statement on file with the SEC. The Subscriber acknowledges that it has a pre-existing
personal or business relationship with either the Company, the Placement Agent or any of their officers, directors or controlling
persons, of a nature and duration such as would enable a reasonable prudent investor to be aware of the character, business acumen,
and general business and financial circumstances of the Company and an investment in the Units.

 

    	 	-6-	 

    	 

    

 

(m)
Organization; Authority. If Subscriber is not a natural person, Subscriber is an entity duly organized, validly existing
and in good standing under the laws of the jurisdiction of its organization with full right, corporate or partnership power and
authority to enter into and to consummate the transactions contemplated by the Offering and otherwise to carry out its obligations
thereunder.

 

(n)
Authority; Enforceability. This Agreement and other agreements delivered together with this Agreement or in connection
herewith have been duly authorized, executed and delivered by the Subscriber and are valid and binding agreements enforceable
in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar
laws of general applicability relating to or affecting creditors’ rights generally and to general principles of equity;
and Subscriber, if not a natural person, has full power and authority necessary to enter into this Agreement and such other agreements
and to perform its obligations hereunder and under all other agreements entered into by the Subscriber relating hereto.

 

(o)
Correctness of Representations. Each Subscriber represents that the foregoing representations and warranties are true and
correct as of the date hereof and, unless a Subscriber otherwise notifies the Company prior to the Closing, shall remain true
and correct as of Closing. The foregoing representations and warranties shall survive the Closing Date for a period of three years.

 

(p)
No Tax or Legal Advice. Such Subscriber understands that nothing in this Agreement, any other agreement or any other materials
presented to such Subscriber in connection with the purchase and sale of the Units constitutes legal, tax or investment advice
and such information may not be used, for the purpose of (i) avoiding tax-related penalties under the Internal Revenue Code or
(ii) promoting, marketing or recommending to another party any tax-related matters addressed herein. Such Subscriber has consulted
such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with
its purchase of Units.

 

Circular
230 Disclosure. Pursuant to U.S. Treasury Department Regulations, we are required to advise you that, unless otherwise expressly
indicated, any federal tax advice contained in this communication, including attachments and enclosures, is not intended or written
to be used, and may not be used, for the purpose of (i) avoiding tax-related penalties under the Internal Revenue Code or (ii)
promoting, marketing or recommending to another party any tax-related matters addressed herein.

 

(q)
Questionnaire. The Subscriber has completed the accompanying Questionnaire and has delivered it herewith and represents
and warrants that it is accurate and true in all respects and that it accurately and completely sets forth the financial condition
of the Subscriber on the date hereof. The Subscriber has no reason to expect there will be any material adverse change in its
financial condition and will advise the Company of any such changes occurring prior to the closing or termination of the Offering.

 

    	 	-7-	 

    	 

    

 

(r)
Company Discretion. The Subscriber understands that the Company shall have the right to accept or reject this subscription
in whole or in part. Unless this subscription is accepted in whole or in part by the Company prior to three (3) months from the
date of this Agreement, unless extended, the expiration of the Offering Period, this subscription shall be deemed rejected in
whole. The Subscriber acknowledges that any delivery to it of this Agreement relating to the Units prior to the determination
by the Company of its suitability as a Subscriber shall not constitute an offer of the Units until such determination of suitability
shall be made, and the Subscriber hereby agrees that it shall promptly return the Offering Documents to the Company upon request.

 

(s)
Binding Subscription. The Subscriber hereby acknowledges and agrees, subject to any applicable state securities laws that
the subscription and application hereunder are irrevocable, that the Subscriber is not entitled to cancel, terminate or revoke
this Subscription Agreement and that this Subscription Agreement shall survive the death or disability of the Subscriber and shall
be binding upon and inure to the benefit of the Subscriber and his heirs, executors, administrators, successors, legal representatives,
and assigns. If the Subscriber is more than one person, the obligations of the Subscriber hereunder shall be joint and several,
and the agreements, representations, warranties, and acknowledgments herein contained shall be deemed to be made by and be binding
upon each such person and his heirs, executors, administrators, successors, legal representatives, and assigns.

 

(t)
FINRA Member. The Subscriber acknowledges that if it is an “associated person” or Registered Representative
of a Financial Industry Regulatory Authority, Inc. (“FINRA”) member firm, the Subscriber has given such firm notice
required by the FINRA’s Rules of Fair Practice, receipt of which must be acknowledged by such firm on the signature page
hereof.

 

(u)
Anti-Money Laundering Regulations. The Subscriber hereby acknowledges that the Company’s intent is to comply
with all applicable federal, state and local laws designed to combat money laundering and similar illegal activities, including
the provisions of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism
Act of 2001 (“PATRIOT Act”). In furtherance of such efforts, Subscriber hereby represents, covenants,
and agrees that, to the best of Subscriber’s knowledge, based on reasonable investigation:

 

(i)
None of Subscriber’s investment in the Company shall be derived from money laundering or similar activities deemed illegal
under federal laws and regulations.

 

(ii)
To the extent within Subscriber’s control, none of Subscriber’s investment in the Company will cause the Company,
the Placement Agent or any of their personnel to be in violation of federal anti-money laundering laws, including without limitation
the Bank Secrecy Act (31 U.S.C. 5311 et seq.), the United States Money Laundering Control Act of 1986 or the International Money
Laundering Abatement and Anti-Terrorist Financing Act of 2001, and any regulations promulgated thereunder.

 

    	 	-8-	 

    	 

    

 

(iii)
When requested by the Company or the Placement Agent, the Subscriber will provide any and all additional information deemed reasonably
necessary to ensure compliance with all applicable laws and regulations concerning money laundering and similar activities.

 

(iv)
Except as otherwise disclosed in writing to the Company, the Subscriber represents and warrants neither it, nor any person or
entity controlled by, controlling or under common control with Subscriber, any of Subscriber’s beneficial owners, any person
for whom the Subscriber is acting as agent or nominee in connection with this investment, nor in the case of any Subscriber which
is an entity, any Related Person1 is:

 

A.
a Prohibited Subscriber2;

 

B.
a Senior Foreign Political Figure3, any member of a Senior Foreign Political Figure’s “immediate family,”
which includes the figure’s parents, siblings, spouse, children and in-laws, or any Close Associate4 of a
Senior Foreign Political Figure, or a person or entity resident in, or organized or chartered under, the laws of a Non-Cooperative
Jurisdiction5;

 

C.
a person or entity resident in, or organized or chartered under, the laws of a jurisdiction that has been designated by the U.S.
Secretary of the Treasury under Section 311 or 312 of the PATRIOT Act as warranting special measures due to money laundering concerns;
or

 

D.
a person or entity who gives Subscriber reason to believe that its funds originate from, or will be or have been routed through,
an account maintained at a Foreign Shell Bank, 6 an “offshore bank,” or a bank organized or chartered under
the laws of a Non-Cooperative Jurisdiction.

 

 

1
With respect to any entity, any interest holder, director, senior officer, trestee, beneficiary or grantor of such entity;
provided that in the case of an entity that is a publicly traded company or a tax qualified pension or retirement plan
in which at least 100 employees participate that is maintained by an employer that is organized in the U.S. or is a U.S. government
entity (a “Qualified Plan”), the term “Related Person” shall exclude any interest holder
holding less than 5% of any class of securities of such publicly traded company and beneficiaries of such Qualified Plan.

 

2
For purposes of this subparagraph (d), “Prohibited Subscriber” shall mean a person or entity whose
name appears on (i) the List of Specially Designated Nationals and Blocked Persons maintained by the U.S. Office of Foreign Assets
Control; (ii) other lists of prohibited persons and entities as may be mandated by applicable law or regulation; or (iii) such
other lists of prohibited persons and entities as may be provided to the Company in connection therewith.

 

3
For purposes of this subparagraph (d), “Senior Foreign Political Figure” shall mean a senior official
in the executive, legislative, administrative, military or judicial branches of a foreign government (whether elected or not),
a senior official of a major foreign political party, or a senior executive of a foreign government-owned corporation. In addition,
a Senior Foreign Political Fignre includes any corporation, business or other entity that has been formed by, or for the benefit
of, a Senior Foreign Political Figure.

 

4
For purposes of this subparagraph (d), “Close Associate of a Senior Foreign Political Figure” shall
mean a person who is widely and publicly known internationally to maintain an unusually close relationship with the Senior Foreign
Political Figure, and includes a person who is in a position to conduct substantial domestic and international financial transactions
on behalf of the Senior Foreign Political Figure.

 

5
For purposes of this subparagraph (d), “Non-Cooperative Jurisdiction” shall mean any foreign country
that has been designated as non-cooperative with international anti-money laundering principles or procedures by an intergovernmental
group or organization, such as the Financial Task Force on Money Laundering, of which the U.S. is a member and with which designation
the U.S. representative to the group or organization continues to concur.

 

6
For purposes of this subparagraph (d), “Foreign Shell Bank” shall mean a Foreign Bank without
a Physical Presence in any country, but does not include a Regulated Affiliate.

 

A
“Foreign Bank” shall mean an organization that (i) is organized under the laws of a foreign country,
(ii) engages in the business of banking, (iii) is recognized as a bank by the bank supervisory or monetary authority of the country
of its organization or principal banking operations, (iv) receives deposits to a substantial extent in the regular course of its
business, and (v) has the power to accept demand deposits, but does not include the U.S. branches or agencies of a foreign bank.

 

“Physical
Presence” shall mean a place of business that is maintained by a Foreign Bank and is located at a fixed address,
other than solely a post office box or an electronic address, in a country in which the Foreign Bank is authorized to conduct
banking activities, at which location the Foreign Bank (i) employs one or more individuals on a full-time basis, (ii) maintains
operating records related to its banking activities, and (Hi) is subject to inspection by the banking authority that licensed
the Foreign Bank to conduct banking activities.

 

“Regulated
Affiliate” shall mean a Foreign Shell Bank that (i) is an affiliate of a depository institution, credit union or
Foreign Bank that maintains a Physical Presence in the U.S. or a foreign country regulating such affiliated depository institution,
credit union or Foreign Bank.

 

    	 	-9-	 

    	 

    

 

(v)
If the Subscriber is purchasing the Units as agent, representative, intermediary/nominee or in any particular capacity for any
other person, or is otherwise requested to do so by the Company, it shall provide a copy of its anti-money laundering policies
(“AML Policies”) to the Company. The Subscriber represents that it is in compliance with its
AML Policies, its AML Policies have been approved by counsel or internal compliance personnel reasonably informed of anti- money
laundering policies and their implementation and has not received a deficiency letter, negative report or any similar determination
regarding its AML Policies from independent accountants, internal auditors or some other person responsible for reviewing compliance
with its AML Policies.

 

(vi)
The Subscriber hereby agrees to immediately notify the Company if it knows, or has reason to suspect that any of the representations
in this paragraph 5(u) become incorrect or if there is any change in the information affecting these representations and covenants.

 

(vii)
The Subscriber agrees that, if at any time it is discovered that any of the foregoing anti-money laundering representations are
incorrect, or if otherwise required by applicable laws or regulations related to money laundering and similar activities, the
Company may undertake appropriate actions, and the Subscriber agrees to cooperate with such actions, to ensure compliance with
such laws or regulations, including, but not limited to segregation and/or redemption of the Subscriber’s Investment in
the Company.

 

6.
Company Representations and Warranties. The Company represents and warrants to each Subscriber that:

 

(a)
Due Incorporation. The Company is a corporation duly incorporated, validly existing and in good standing under the laws
of the State of Delaware and has the requisite corporate power to own its properties and to carry on its business as currently
being conducted. The Company’s By-Laws and Amended and Restated Certificate of Incorporation are available at the SEC’s
website, www.sec.gov. The Company, as of the date hereof, has no subsidiaries other than SignPath Brazil Corp. The Company is
duly qualified as a foreign corporation to do business and is in good standing in each jurisdiction where the nature of the business
conducted or property owned by it makes such qualification necessary, unless the failure to be so qualified or in good standing,
as the case may be, would not have or would not reasonably be expected to result in (i) a material adverse effect on the legality,
validity or enforceability of this Agreement or any other document in connection with the Offering, (ii) a material adverse effect
on the results of operations, assets, business or financial condition of the Company, or (iii) a material adverse effect on the
Company’s ability to perform in any material respect on a timely basis its obligations under this Agreement (any of (i),
(ii) or (iii), constituting a “Material Adverse Effect”).

 

    	 	-10-	 

    	 

    

 

(b)
Capitalization; Ownership of Shares. The authorized capital stock of the Company consists of 50,000,000 shares of Common
Stock and 5,000,000 shares of Preferred Stock. As of the date hereof, there are approximately 40,270,237 shares of Common Stock
issued and/or issuable on a fully diluted basis, as follows: (i) 14,163,887 shares of Common Stock are issued and outstanding,
all of which are duly authorized, validly issued, fully paid and nonassessable and were not issued in violation of any preemptive
rights, (ii) 3,255.375 shares of Series A Preferred Stock are issued and outstanding and convertible into approximately 3,831,576
shares of Common Stock, all of which are duly authorized, validly issued, fully paid and nonassessable and were not issued in
violation of any preemptive rights; (iii) approximately 3,831,576 shares of Common Stock issuable upon exercise of outstanding
Class A Warrants; (iv) 2,146 shares of Series B Preferred Stock are issued and outstanding and convertible into approximately
2,525,842 shares of Common Stock; (v) approximately 2,525,842 shares of Common Stock issuable upon exercise of outstanding Class
B Warrants; (vi) 5,000 shares of Series C Preferred Stock are issued and outstanding and convertible into approximately 4,000,000
shares of Common Stock; (vii) 2,000,000 shares of Common Stock issuable upon exercise of outstanding Class C Warrants; (viii)
2,359.076 shares of Series D Preferred Stock are issued and outstanding and convertible into 1,179,538 shares of Common Stock;
(ix) 294,888 shares of Common Stock are issuable upon exercise of outstanding Class D Warrants; (x) approximately 3,402,088 shares
issuable upon exercise of outstanding Placement Agent Warrants; (xi) 800,000 shares issuable upon exercise of warrants authorized
to the Company’s manufacturer of curcumin; and (xii) 1,715,000 shares issuable upon exercise of 1,715,000 outstanding stock
options. Except for the transactions contemplated hereby and as described in the Memorandum, there are no outstanding options,
warrants, convertible securities or other rights, agreements, arrangements or commitments relating to the Common Stock or obligating
the Company to issue or sell any shares of Common Stock, or any other interest in, the Company. All outstanding shares of capital
stock of the Company were issued, sold and delivered in material compliance with all applicable Federal and state securities laws
and the similar laws of other foreign jurisdictions as may be applicable. No person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by this Offering or otherwise.
The issue and sale of the Units will not obligate the Company to issue shares of Common Stock or other securities to any person
(other than the Subscribers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion,
exchange or reset price under such securities.

 

(c)
Authority; Enforceability. This Agreement and the Securities have been duly authorized, executed and delivered by the Company
and are valid and binding agreements enforceable in accordance with their terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights
generally and to general principles of equity, and the Company has full corporate power and authority necessary to enter into
this Agreement, the Warrants, the Escrow Agreement, and such other agreements and to perform its obligations hereunder and under
all other agreements entered into by the Company relating hereto. All corporate action on the part of the Company by its officers,
directors and stockholders necessary for the authorization, execution and delivery of, and the performance by the Company of its
obligations under this Agreement and the other agreements entered into as contemplated by this Agreement has been taken. 

 

    	 	-11-	 

    	 

    

 

(d)
Consents. No consent, approval, authorization or order of any court, governmental agency or body or arbitrator having jurisdiction
over the Company, or over any of its affiliates, FINRA, Nasdaq, the OTC Bulletin Board nor the Company’s stockholders is
required for execution of this Agreement and all other agreements entered into by the Company relating thereto, including, without
limitation, the issuance and sale of the Securities, and the performance of the Company’s obligations hereunder and under
all such other agreements.

 

(e)
No Violation or Conflict. Assuming the representations and warranties of the Subscribers in Section 5 are true and correct,
neither the execution and delivery of this Agreement nor the issuance and sale of the Securities nor the performance of the Company’s
obligations under this Agreement and all other agreements entered into by the Company relating thereto by the Company will:

 

(i)
violate, conflict with, result in a material breach of, or constitute a default (or an event which with the giving of notice or
the lapse of time or both would be reasonably likely to constitute a default) or give to others any rights of termination, amendment,
acceleration or cancellation under (A) the certificate of incorporation or bylaws of the Company, (B) any decree, judgment, order,
law, treaty, rule, regulation or determination applicable to the Company of any court, governmental agency or body, or arbitrator
having jurisdiction over the Company or any of its affiliates (including federal and state securities laws and regulations) or
over the properties or assets of the Company or any of its affiliates, (C) the terms of any bond, debenture, note or any other
evidence of indebtedness, or any agreement, stock option or other similar plan, indenture, lease, mortgage, deed of trust or other
instrument to which the Company or any of its affiliates is a party, by which the Company or any of its affiliates is bound or
affected, or to which any of the properties or assets of the Company or any of its affiliates is subject, or (D) the terms of
any “lock-up” or similar provision of any underwriting or similar agreement to which the Company, or any of its affiliates
is a party except the violation, conflict, breach, or default of which would not have a Material Adverse Effect on the Company;
or

 

(ii)
result in the creation or imposition of any lien, charge or encumbrance upon the securities or any of the assets of the Company
or any of its affiliates.

 

    	 	-12-	 

    	 

    

 

(f)
The Securities. The Securities upon issuance:

 

(i)
are, or will be, free and clear of any security interests, liens, claims or other encumbrances, subject to restrictions upon transfer
under the 1933 Act and any applicable state securities laws;

 

(ii)
have been, or will be, duly and validly authorized and on the date of issuance will be duly and validly issued, fully paid and
nonassessable (and if eventually registered pursuant to the 1933 Act, and resold pursuant to an effective registration statement
will be free trading and unrestricted, provided that each Subscriber complies with the prospectus delivery requirements of the
1933 Act and any state securities laws);

 

(iii)
will not have been issued or sold in violation of any preemptive or other similar rights of the holders of any securities of the
Company; and

 

(iv)
will not subject the holders thereof to personal liability by reason of being such holders.

 

(g)
Litigation. There is no pending or, to the knowledge of the Company, threatened action, suit, proceeding inquiry, notice
of violation, or investigation before any court, governmental or administrative agency or regulatory body (federal, state, county,
local or foreign), or arbitrator having jurisdiction over the Company, or any of its affiliates that would challenge the legality,
validity or enforceability of this Agreement and/or the Offering, or otherwise affect the execution by the Company or the performance
by the Company of its obligations under this Agreement, and all other agreements entered into by the Company relating hereto.
Except as disclosed in the Offering Documents, there is no pending or, to the knowledge of the Company, threatened action, suit,
proceeding or investigation before any court, governmental agency or body, or arbitrator having jurisdiction over the Company,
or any of its affiliates which litigation if adversely determined would have a Material Adverse Effect on the Company.

 

(h)
Defaults; Permits. The Company is not in violation of its Certificate of Incorporation or By-Laws. The Company is (i) not
in default under or in violation of any other material agreement or instrument to which it is a party or by which it or any of
its properties are bound or affected, which default or violation would have a Material Adverse Effect on the Company, (ii) not
in default with respect to any order of any court, arbitrator or governmental body or subject to or party to any order of any
court or governmental authority arising out of any action, suit or proceeding under any statute or other law respecting antitrust,
monopoly, restraint of trade, unfair competition or similar matters, or (iii) to its knowledge in violation of any statute, rule
or regulation of any governmental authority which violation would have a Material Adverse Effect on the Company. The Company possesses
all material certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities
necessary to conduct their respective businesses other than where the failure to possess such certificates, authorizations or
permits, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect.
The Company has not received any notice or otherwise become aware of any proceedings, inquiries or investigations relating to
the revocation or modification of any such certificate, authorization or permit.

 

    	 	-13-	 

    	 

    

 

(i)
No General Solicitation. Neither the Company, nor any of its affiliates, nor to the Company’s knowledge, any person
acting on its or their behalf, has, directly or indirectly made any offers or sales of any security or solicited any offers to
buy any security that would cause the offer of the Securities pursuant to this Agreement to be integrated with prior offerings
by the Company for purposes of the 1933 Act or any applicable stockholder approval provisions. Neither the Company nor any of
its affiliates will take any action or steps that would cause the offer of the Securities to be integrated with other offerings
if such integration would eliminate the Offering Exemption. Neither the Company nor any of its affiliates, nor to the Company’s
knowledge, any person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within
the meaning of Regulation D) in connection with the offer or sale of the Units. 

 

(j)
Disclosure. None of the representations and warranties of the Company appearing in this Agreement nor any information appearing
in any of the Offering Documents, when considered together as a whole, contains, or on the Closing will contain any untrue statement
of a material fact or omits, or on the Closing will omit, to state any material fact required to be stated herein or therein in
order for the statements herein or therein, in light of the circumstances under which they were made, not to be misleading.

 

(k)
No Undisclosed Liabilities or Events. The Company has no liabilities or obligations which are material, individually or
in the aggregate, which are not disclosed in the Offering Documents, other than those incurred in the ordinary course of the Company’s
businesses since September 30, 2015. There has been no event or circumstance that has occurred or exists with respect to the Company
or its businesses, properties, operations or financial condition, that, under applicable law, rule or regulation, requires disclosure
but which has not been so publicly announced or disclosed in the Offering Documents.

 

(l)
Intellectual Property. The Company owns, free and clear of claims or rights of any other person, with full right to use,
sell, license, sublicense, dispose of, and bring actions for infringement of, or has acquired licenses or other rights to use,
all intellectual property necessary for the conduct of its business as presently conducted (other than with respect to “off-the-shelf”
software which is generally commercially available and open source software which may be subject to one or more “general
public” licenses. A complete list of patents, pending patent applications and all other intellectual property is available
upon request from the Company. The business of the Company as presently conducted does not, to the Company’s knowledge,
infringe or conflict with any patent, trademark, copyright, or trade secret rights of any third parties or any other intellectual
property of any third parties. The Company has not received written notice from any third party asserting that any intellectual
property owned or licensed by the Company, or which the Company otherwise has the right to use, is invalid or unenforceable by
the Company and, to the Company’s knowledge, there is no valid basis for any such claim (whether or not pending or threatened).
No claim is pending or, to the Company’s knowledge, threatened against the Company nor has the Company received any written
notice or other written claim from any person asserting that any of the Company’s present or contemplated activities infringe
or may infringe in any material respect any intellectual property of such person, and the Company is not aware of any infringement
by any other Person of any material rights of the Company under any intellectual property rights. The Company has taken all steps
required in accordance with commercially reasonable business practice to establish and preserve its respective ownership in its
intellectual property and to keep confidential all material technical information developed by or belonging to the Company which
has not been patented or copyrighted.

 

    	 	-14-	 

    	 

    

 

(m)
Investment Company Status. The Company is not, and immediately after receipt of the Final Closing will not be, an “investment
company” or an entity “controlled” by an “investment company” within the meaning
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), and the Company shall conduct
its business in a manner so that it will not become subject to the Investment Company Act.

 

(n)
Taxes. The Company (i) has prepared in good faith and duly and timely filed all tax returns required to be filed by it
or is on a current extension and such returns are complete and accurate in all material respects and (ii) has paid all taxes required
to have been paid by it, except for taxes which it reasonably disputes in good faith or the failure of which to pay has not had
or would not reasonably be expected to have a Material Adverse Effect. The Company has no any liability with respect to accrued
taxes in excess of the amounts that are described as accrued in the most recent financial statements included in the Offering
Documents.

 

(o)
Solvency. The Company has no knowledge of any facts or circumstances which lead it to believe that it will be required
to file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction and has no present intention
to so file.

 

(p)
Transactions with Interested Persons. Except as described in the Prospectus, no officer, director, employee or affiliate
of the Company is or has taken any steps to become a party to any transaction with the Company (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner.

 

(q)
No Other Agreements. The Company has not, directly or indirectly, entered into any agreement with or granted any right
to any Subscriber relating to the terms or conditions of the transactions contemplated by this Agreement or the other Offering
Documents except as expressly set forth therein.

 

    	 	-15-	 

    	 

    

 

(r)
Correctness of Representations. The Company represents that the foregoing representations and warranties are true and correct
as of the date hereof in all material respects. The foregoing representations and warranties shall survive until one year after
the Closing Date.

 

7.
Regulation D/Regulation S Offering. This Offering is being made pursuant to exemptions from the registration provisions
of the 1933 Act afforded by: (i) Section 4(a)(2) and/or Rule 506 of Regulation D promulgated thereunder, or (ii) Rule 903 of Regulation
S promulgated thereunder.

 

8.
Reissuance of Securities. The Company agrees to reissue certificates representing the Underlying Shares without the legends
set forth in Sections 5(j) and 5(k) above, (a) at such time as the holder thereof is permitted to dispose of the Securities without
volume or manner of sale restrictions pursuant to Rule 144 under the 1933 Act in the opinion of counsel reasonably satisfactory
to the Company, or (b) upon resale subject to an effective registration statement after the resale of the shares of Common Stock
and Common Stock underlying the Warrants is registered under the 1933 Act. The Company agrees to cooperate with each Subscriber
in connection with all resales pursuant to Rule 144 and to provide legal opinions at the Company’s expense necessary to
allow such resales provided the Company and its counsel receive reasonably requested written representations from each Subscriber
and its selling broker, if any. 

 

9.
FINRA Member Firm Compensation. The Company on the one hand, and each Subscriber on the other hand, agree to indemnify
the other against and hold the other harmless from any and all liabilities to any persons claiming brokerage commissions other
than Meyers Associates, L.P. on account of services purported to have been rendered on behalf of the indemnifying party in connection
with this Agreement or the transactions contemplated hereby and arising out of such party’s actions. However, Meyers Associates,
L.P. may engage other FINRA registered firms and pay negotiated compensation to such selling group members. The Company shall
pay the Placement Agent sales commission(s) equal to 10% of the gross proceeds from the sale of Units, as well as 3% non-accountable
expense allowance. The Placement Agent will also receive warrants to purchase up to 20% of the Units sold at $2.00 per Unit. The
Company will pay the Placement Agent a cash fee equal to 10% of the total cash proceeds received from the exercise of Warrants.

 

10.
Covenants of the Company. At all times shares of Common Stock and Warrants remain outstanding, the Company covenants and
agrees with the Subscribers as follows:

 

(a)
Reservation of Common Stock. The Company undertakes to reserve from its authorized but unissued common stock, at all times
Warrants remain outstanding, a number of Underlying Shares equal to the amount of Common Stock issuable upon exercise of the Warrants.

 

(b)
Confidentiality. Subject to being named in the Company’s SEC filings, the Company agrees that it will not disclose
publicly or privately the identity of any Subscriber unless expressly agreed to in writing by that Subscriber or only to the extent
required by law.

 

    	 	-16-	 

    	 

    

 

(c)
Reporting Requirements. The Company will (i) cause its Common Stock to continue to be registered under Section 12(b) or
12(g) of the 1934 Act following the completion of the Offering, or (ii) comply in all respects with its reporting and filing obligations
under the 1934 Act, (iii) comply with all reporting requirements that are applicable to an issuer with a class of shares registered
pursuant to Section 15(d) of the 1934 Act, as applicable, and (iv) comply with all requirements related to any registration statement
filed pursuant to this Agreement. The Company will use its best efforts to not take any action or file any document (whether or
not permitted by the 1933 Act or the 1934 Act or the rules thereunder) to terminate or suspend such registration or to terminate
or suspend its reporting and filing obligations under said acts. Until the earlier of the resale of the Shares and Underlying
Shares by each Subscriber or at least one (1) year after the Warrants have been exercised, the Company will use reasonable efforts
to continue the listing or quotation, if listed, of the Common Stock on the Principal Market and will comply in all respects with
the Company’s reporting, filing and other obligations under the bylaws or rules of the Principal Market, however will be
under no obligation to have its securities listed or quoted.

 

(d)
Stop Orders. Following effectiveness of the Registration Statement, the Company will advise the Subscribers, promptly after
it receives notice of issuance by the SEC, any state securities commission or any other regulatory authority of any stop order
or of any order preventing or suspending any offering of any securities of the Company, or of the suspension of the qualification
of the Common Stock of the Company for offering or sale in any jurisdiction, or the initiation of any proceeding for any such
purpose.

 

(e)
Use of Proceeds. The proceeds received by the Company in the Offering will be used by the Company as set forth in the Memorandum
under “Use of Proceeds”.

 

(f)
Taxes. The Company will promptly pay and discharge, or cause to be paid and discharged, when due and payable, all material
lawful taxes, assessments and governmental charges or levies imposed upon the income, profits, property or business of the Company;
provided, however, that any such tax, assessment, charge or levy need not be paid if the validity thereof shall
currently be contested in good faith by appropriate proceedings and if the Company shall have set aside on its books adequate
reserves with respect thereto; and provided, further, that the Company will pay all such material taxes, assessments,
charges or levies forthwith upon the commencement of proceedings to foreclose any lien which may have attached as security therefor.

 

(g)
Insurance. The Company is or will be insured by insurers of recognized financial responsibility against such material losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company is engaged. The Company has
no current reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business. The Company will keep its assets
which are of an insurable character insured by financially sound and reputable insurers against loss or damage by fire, explosion
and other risks customarily insured against by companies in the Company’s line of business, in amounts sufficient to prevent
the Company from becoming a co-insurer and not in any event less than 100% of the insurable value of the property insured; and
the Company will maintain, with financially sound and reputable insurers, insurance against other hazards and risks and liability
to persons and property to the extent and in the manner customary for companies in similar businesses similarly situated and to
the extent available on commercially reasonable terms.

 

    	 	-17-	 

    	 

    

 

(h)
Books and Records. The Company will keep true records and books of account in which full, true and correct entries will
be made of all dealings or transactions in relation to its business and affairs in accordance with generally accepted accounting
principles applied on a consistent basis.

 

(i)
Governmental Authorities. The Company shall duly observe and conform in all material respects to all valid requirements
of governmental authorities relating to the conduct of its business or to its properties or assets.

 

(j)
Properties. The Company will keep its properties in good repair, working order and condition, reasonable wear and tear
excepted, and from time to time make all needful and proper repairs, renewals, replacements, additions and improvements thereto;
and the Company will at all times comply with each provision of all leases to which it is a party or under which it occupies property
if the breach of such material provision could reasonably be expected to have a Material Adverse Effect.

 

11.
Covenants of the Company and Subscriber Regarding Indemnification.

 

(a)
The Company agrees to indemnify, hold harmless, reimburse and defend the Subscribers, the Subscribers’ officers, directors,
agents, affiliates, control persons, and principal shareholders, against any claim, cost, expense, liability, obligation, loss
or damage (including reasonable legal fees) of any nature, incurred by or imposed upon the Subscriber or any such person which
results, arises out of or is based upon (i) any material misrepresentation by Company or breach of any warranty by Company in
this Agreement or in any Exhibits or Schedules attached hereto, or other agreement delivered pursuant hereto; or (ii) after any
applicable notice and/or cure periods, any breach or default in performance by the Company of any covenant or undertaking to be
performed by the Company hereunder, or any other agreement entered into by the Company and Subscriber relating hereto.

 

(b)
Each Subscriber agrees to indemnify, hold harmless, reimburse and defend the Company and each of the Company’s officers,
directors, agents, affiliates, control persons, and principal shareholders against any claim, cost, expense, liability, obligation,
loss or damage (including reasonable legal fees) of any nature, incurred by or imposed upon the Company or any such person which
results, arises out of or is based upon (i) any material misrepresentation by such Subscriber in this Agreement or in any Exhibits
or Schedules attached hereto, or other agreement delivered pursuant hereto; or (ii) after any applicable notice and/or cure periods,
any breach or default in performance by such Subscriber of any covenant or undertaking to be performed by such Subscriber hereunder,
or any other agreement entered into by the Company and Subscribers relating hereto.

 

    	 	-18-	 

    	 

    

 

12.
Miscellaneous.

 

(a)
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder
shall be in writing and, unless otherwise specified herein, shall be either (i) personally served, (ii) deposited in the mail,
registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges
prepaid, or (iv) transmitted by hand delivery, electronic mail, or facsimile, addressed as set forth below or to such other address
as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to
be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated
by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received), (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
or (c) upon acknowledgment of by the recipient of receipt by electronic mail, whichever shall first occur. The addresses for such
communications shall be:

 

	 	(i)
    if to the Company, to: 	SignPath
    Pharma Inc.
	 	 	3477
    Corporate Parkway, Suite 100
	 	 	Center
    Valley, Pennsylvania 18034 
	 	 	Attention:
    Dr. Lawrence Helson
	 	 	Tel:
    (215) 538-9996
	 	 	Email:
    lhelson@comcast.com
	 	 	 
	 	With
    a copy to:	Davidoff
    Hutcher & Citron LLP
	 	 	605
    Third Avenue, 34th Floor
	 	 	New
    York, N.Y. 10158
	 	 	Attention:
    Elliot H. Lutzker, Esq.
	 	 	Email:
    ehl@dhclegal.com 
	 	 	Fax:
    (212) 286-1884
	 	 	 
	 	(ii)
    if to the Subscribers, 	to
    the address and facsimile number indicated on the signature pages hereto
	 	 	 
	 	With
    a copy to: 	Meyers
    Associates, L.P.
	 	 	45
    Broadway, 2nd Floor
	 	 	New
    York, N.Y. 10006
	 	 	Attention:
    Bruce Meyers
	 	 	Tel:
    (212) 742-4200
	 	 	Email:
    eslitkin@meyersassociateslp.com
	 	 	Fax:
    (212) 742-4222

 

    	 	-19-	 

    	 

    

 

(b)
Entire Agreement. This Agreement and other documents delivered in connection herewith represent the entire agreement between
the parties hereto with respect to the subject matter hereof and may be amended only by a writing executed by all parties. Neither
the Company nor the Subscribers have relied on any representations not contained or referred to in this Agreement and the documents
delivered herewith, except as contained in the Reports.

 

(c)
Assignment. No right or obligation of any party may be assigned by that party without the prior written consent of all
other parties. This Agreement will be binding on the successors and assigns of all parties hereto.

 

(d)
Counterparts. This Agreement may be executed by facsimile transmission, and in counterparts, all of which together will
be deemed one original.

 

(e)
Law Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State
of Delaware without regard to principles of conflicts of laws. All actions arising out of or relating to this Agreement shall
be heard and determined exclusively in any New York federal court sitting in the Borough of Manhattan of The City of New York;
provided, however, that if such federal court does not have jurisdiction over such action, such action shall be
heard and determined exclusively in any New York state court sitting in the Borough of Manhattan of The City of New York. Consistent
with the preceding sentence, the parties hereto hereby (a) submit to the exclusive jurisdiction of any federal or state court
sitting in the Borough of Manhattan of The City of New York for the purpose of any action arising out of or relating to this Agreement
brought by any party hereto and (b) irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any
such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt
or immune from attachment or execution, that the action is brought in an inconvenient forum, that the venue of the action is improper,
or that this Agreement or the transactions contemplated by this Agreement may not be enforced in or by any of the above-named
courts.

 

(f)
Waiver of Jury Trial. EACH OF the parties hereto hereby waiveS to the fullest extent
permitted by applicable law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising
out of, under or in connection with this Agreement or the transactions contemplated by this Agreement. EACH OF the parties hereto
hereby (a) certifies that no representative, agent or attorney of the other party has represented, expressly or otherwise, that
such other party would not, in the event of litigation, seek to enforce the foregoing waiver and (b) acknowledges that it has
been induced to enter into this Agreement and the transactions contemplated by this Agreement, as applicable, by, among other
things, the mutual waivers and certifications in this Section 12(f).

 

(g)
Severability. In the event that any provision of this Agreement or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the
extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision
which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision
of any agreement.

 

(g)
Headings. All headings contained herein are inserted only for convenience and ease of reference and are not to be considered
in the construction or interpretation of any provision of this Agreement.

 

[Signature
page to follow]

 

    	 	-20-	 

    	 

    

 

SIGNATURE
PAGE TO SUBSCRIPTION AGREEMENT

 

In
Witness Whereof, the parties have entered
into this Agreement as of the date below.

 

	Dated:
    __________, 2016	SignPath
    Pharma Inc.,
	 	a
    Delaware corporation
	 	 
	 	By:	 
	 	 	Lawrence
    Helson, M.D.
	 	 	Chief
    Executive Officer

 

	Name
    of Subscriber:	 	 

 

	Name
    of Authorized Signatory (if different from Subscriber):	 	 

 

	Title
    of Authorized Signatory:	 	 

 

	Signature
    of Authorized Signatory or Subscriber:	 	 

 

	EIN
    or Social Security Number:	 	 

 

	Email
    Address of Subscriber:	 	 

 

	Facsimile
    Number of Subscriber:	 	 

 

	Address
    for Notice to Subscriber:	 	 

 

	Address
    for Delivery of Securities for Subscriber (if not same as address for notice):	 	 

 

	Subscription
    Amount: $	 	 

 

	Units:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}]]